Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-730-9 | CAS number: 5036-48-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August - October 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Harlan Cytotest Cell Research GmbH, 64380 Rossdorf, Germany
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 1H-imidazole-1-propylamine
- EC Number:
- 225-730-9
- EC Name:
- 1H-imidazole-1-propylamine
- Cas Number:
- 5036-48-6
- Molecular formula:
- C6H11N3
- IUPAC Name:
- 3-(1H-imidazol-1-yl)propan-1-amine
- Details on test material:
- - Name of test material (as cited in study report): N-(3-Aminopropyl) imidazol
- Physical state: liquide
- Analytical purity: 99.2 %
- Lot/batch No.: O 2894
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Sulzfeld, Germany
- Age at study initiation: 8 - 9 weeks
- Weight at study initiation: mean value 35.6 g (SD+/_ 1.9 g)
- Assigned to test groups randomly: yes
- Housing: single
- Diet (e.g. ad libitum): pelleted standard diet, ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): 45 - 110 %
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: sterile water
- Duration of treatment / exposure:
- 24 and 48 hours
- Frequency of treatment:
- once
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
1500, 750 and 375 mg/kg (24h)
Basis:
nominal in water
- Remarks:
- Doses / Concentrations:
1500 mg/kg (48h)
Basis:
nominal in water
- No. of animals per sex per dose:
- 7 animals (except the vehicle and positive control grous with 5 males only)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide (CPA)
Examinations
- Tissues and cell types examined:
- Bone marrow cells were collected for micronuclei analysis.
- Evaluation criteria:
- A test item is classified as mutagenic if it induces either a dose-related increase or a clear increase in the number of micronucleated polychromatic erythrocytes in a single dose group.
- Statistics:
- Statistical methods (nonparametric Mann-Whitney test (8)) are used as an aid in evaluating the results, if necessary. However, the primary point of consideration is the biological relevance of the results.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- see additional information below
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Pre-Experiment for Toxicity
Two animals of each sex treated in the pre-experiments received the test item N-(3-Aminopropyl) imidazol dissolved in sterile water once orally. The volume administered was 10 mL/kg b.w.. The following dose levels were tested and the expressed toxic reactions are shown:
1st pre-experiment: 2000 mg/kg; males/females
2nd pre-experiment: 1000 mg/kg; males/females
3rd pre-experiment: 1500 mg/kg; males/females
Following the 1st pre-experiment severe symptoms were observed during autopsy of one male and one female animal. Visible necrotic damage was observed e.g. on liver, inner abdominal wall, spleen, pancreas and gastrointestinal tract. The stomach of the animals showed extremely severe symptoms such as enlargement and stomach rupture.
On the basis of these data 1500 mg/kg b.w. were estimated to be suitable as highest dose.
No substantial sex specific differences were observed with regard to clinical signs. In agreement with the sponsor the main study was performed using males only.
Toxic Symptoms in the Main Experiment
In the main experiment for each test item dose groups 7 males received once orally administrations of N-(3-Aminopropyl) imidazol dissolved in sterile water. The volume administered was 10 mL/kg b.w.. The syndromes of toxicity observed following treatment are:
375 mg/kg: No toxic reaction was observed.
750 kg/kg: reduction of spontaneous activity, ruffled fur
1500 mg/kg: reduction of spontaneous acitvity, fuffled fur, Hunchback
The animals treated with the negative control (sterile water) did not express any toxic reaction.
After treatment with the test item the number of PCEs was not decreased as compared to the mean value of PCEs of the vehicle control thus indicating that N-(3-Aminopropyl) imidazol did not exert any cytotoxic effects in the bone marrow.
In comparison to the corresponding vehicle controls there was no statistically significant or biologically relevant enhancement in the frequency of thedetected micronuclei at any preparation interval and dose level after administration of the test item. The mean values of micronuclei observed after treatment with N-(3-Aminopropyl) imidazol were near or below to the value of the vehicle control group.
Cyclophosphamide administered orally [40 mg/kg b.w.; 10 mL/kg b.w.; once] was used as positive control which showed a substantial and biologically relevant increase of induced micronucleus frequency.
In conclusion, it can be stated that during the study described and under the experimental conditions reported, the test item did not induce micronuclei as determined by the micronucleus test in the bone marrow cells of the mouse.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse. Therefore, N-(3-Aminopropyl)-imidazol is considered to be non-mutagenic in this micronucleus assay. - Executive summary:
N-(3-Aminopropyl)-imidazol was tested in a MNT in mice in concentrations between 375, 750 and 1500 mg/kg (OECD474; BASF SE, 2011). After treatment with the test item the number of PCEs was not decreased as compared to the mean value of PCEs of the vehicle control thus indicating that N-(3-Aminopropyl)-imidazol did not exert any cytotoxic effects in the bone marrow. In comparison to the corresponding vehicle controls there was no statistically significant or biologically relevant enhancement in the frequency of thedetected micronuclei at any preparation interval and dose level after administration of the test item. The mean values of micronuclei observed after treatment with N-(3-Aminopropyl)-imidazol were near or below to the value of the vehicle control group. Cyclophosphamide administered orally [40 mg/kg b.w.; 10 mL/kg b.w.; once] was used as positive control which showed a substantial and biologically relevant increase of induced micronucleus frequency. The test item did not induce micronuclei as determined by the micronucleus test in the bone marrow cells of the mouse.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.